|
⚲
|
| Keyboard |
| Ayala Pharmaceuticals Inc
✚
|
|
|---|---|
| CIK # | 0001100397, 0001797336 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001100397] | |
| 10-Q | [0001100397] | |
| 3 | [0001100397] | |
| 4 | [0001100397] | |
| 8-K | [0001100397] | |
| D | [0001100397] | |
| SC 13D | [0001100397] | |
| SC 13G | [0001100397] | |
| 10-K | [0001797336] | |
| 10-Q | [0001797336] | |
| 3 | [0001797336] | |
| 4 | [0001797336] | |
| 8-K | [0001797336] | |
| SC 13G | [0001797336] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ayala Pharmaceuticals Inc ADXS
Warrants · derivative
|
2024-03-01 | Option exercise | 2,250,000 | ||
|
Ayala Pharmaceuticals Inc ADXS
Rights · derivative
|
2024-03-01 | Option exercise | 3,750,000 | ||
|
Ayala Pharmaceuticals Inc ADXS
Convertible Promissory Note · derivative
|
2024-03-01 | Option exercise | 1,500,000 | ||
|
Ayala Pharmaceuticals Inc ADXS
Warrants · derivative
|
2024-03-01 | Option exercise | 2,250,000 | ||
|
Ayala Pharmaceuticals Inc ADXS
Rights · derivative
|
2024-03-01 | Option exercise | 3,750,000 | ||
|
Ayala Pharmaceuticals Inc ADXS
Convertible Promissory Note · derivative
|
2024-03-01 | Option exercise | 1,500,000 | ||
|
Ayala Pharmaceuticals Inc ADXS
Warrants · derivative
|
2024-02-07 | Option exercise | 8,062,500 | ||
|
Ayala Pharmaceuticals Inc ADXS
Common Stock, par value $0.001 per share
|
2024-02-07 | Tax withheld | 2,586,905 | $1.25 | 3,233,631 |
|
Ayala Pharmaceuticals Inc ADXS
Convertible Promissory Note · derivative
|
2024-02-07 | Option exercise | 3,887,438 | ||
|
Ayala Pharmaceuticals Inc ADXS
Common Stock, par value $0.001 per share
|
2024-02-07 | Option exercise | 8,062,500 | $0.40 | 3,225,000 |
|
Ayala Pharmaceuticals Inc ADXS
Common Stock, par value $0.001 per share
|
2024-02-07 | Option exercise | 3,887,438 | $0.40 | 1,554,975 |
|
Ayala Pharmaceuticals Inc ADXS
Convertible Promissory Note · derivative
|
2024-02-07 | Option exercise | 4,237,687 | ||
|
Ayala Pharmaceuticals Inc ADXS
Common Stock, par value $0.001 per share
|
2024-02-07 | Option exercise | 1,295,813 | $0.40 | 518,325 |
|
Ayala Pharmaceuticals Inc ADXS
Common Stock, par value $0.001 per share
|
2024-02-07 | Option exercise | 1,926,221 | $0.40 | 770,488 |
|
Ayala Pharmaceuticals Inc ADXS
Common Stock, par value $0.001 per share
|
2024-02-07 | Tax withheld | 2,707,581 | $1.25 | 3,384,476 |
|
Ayala Pharmaceuticals Inc ADXS
Convertible Promissory Note · derivative
|
2024-02-07 | Option exercise | 1,295,813 | ||
|
Ayala Pharmaceuticals Inc ADXS
Warrants · derivative
|
2024-02-07 | Option exercise | 8,437,500 | ||
|
Ayala Pharmaceuticals Inc ADXS
Common Stock, par value $0.001 per share
|
2024-02-07 | Option exercise | 4,237,687 | $0.40 | 1,695,075 |
|
Ayala Pharmaceuticals Inc ADXS
Convertible Promissory Note · derivative
|
2024-02-07 | Option exercise | 1,926,221 | ||
|
Ayala Pharmaceuticals Inc ADXS
Common Stock, par value $0.001 per share
|
2024-02-07 | Option exercise | 8,437,500 | $0.40 | 3,375,000 |
| showing 20 of 200 most recent transactions | |||||